Team Papa Rolls Again!

Neil, Hugh & Sarah Crawford (Team Papa) are training to participate in the Seattle to Portland Bicycle Classic, July 9&10. We ride in thanks to LLS for funding Rituxan®: A Targeted Therapy for Lymphoma that was a major component of our father, BIll Crawford's treatment - which extended his life over 14 years and gave him treasured time with all of his grandchildren.

Rituxan®, a monoclonal antibody drug, was FDA approved for follicular non-Hodgkin lymphoma (NHL) patients in 1997. In fact, it was the very first targeted drug approved in the U.S. LLS-funded researchers found that Rituxan® can dramatically improve chemotherapy effectiveness, and the FDA approved Rituxan® to be used in combination with other chemotherapy drugs for people with follicular lymphoma and other non-Hodgkin lymphoma types. It's contributed to a doubling of the survival rate for NHL patients, and is now also FDA approved as a treatment for patients with chronic lymphocytic leukemia or Hodgkin lymphoma.

For more information on other research milestone that we (LLS) are funding go to http://www.lls.org/#/aboutlls/researchsuccesses. There’s more fuel for the fundraising fire.

All of us on Team In Training are raising funds to help stop leukemia, lymphoma, Hodgkin lymphoma and myeloma from taking more lives. We are completing this event in honor of all individuals who are battling blood cancers. These people are the real heroes on our team, and we need your support to cross the ultimate finish line - a cure!

Join Team Papa today with a donation, no matter how small (or large)! Donating is easier than spending every weekend in spandex, dining on Clif Bars & Gatorade.

We hope you will visit this web site often. Be sure to check back frequently to see our progress. Thanks for your support!